| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |